Conserved peptide with therapeutic potential to overcome nasopharyngeal carcinoma

Closed

Rifa'i Muhaimin, S. Widyarti, N. Widodo

2014 International Medical Journal Malaysia Vol. 13 Issue 1 Article Cited by 2

Abstract

Nasopharyngeal carcinoma (NPC) is a squamous-cell carcinoma that arises in the upper lining epithelium of the nasopharynx. In this study, conserved peptide (Ulin-1) of Epstein-Barr virus constructed by Biomodelling and Biocomputation was tested for its ability to stimulate B cells to produce specific antibodies. Spleen cells were isolated and cultured with anti-CD3 and lipopolysaccharide (LPS), and treated or not treated with Ulin-1. Cell culture was harvested six days after incubation and analyzed by flow cytometry. Here, we demonstrated the ability of Ulin-1 to stimulate B cells to produce specific antibodies. The results of this study illustrate the importance of Ulin-1 engineered by Biomodelling and Biocomputation as both active and passive immunization agents against nasopharyngeal cancer.

Affiliations

Department of Immunology, Faculty of Sciences, Brawijaya University, Malang 65145, Indonesia; Department of Molecular Biology, Faculty of Sciences, Brawijaya University, Malang, Indonesia; Department of Oncology and Biocomputation, Faculty of Sciences, Brawijaya University, Malang, Indonesia